These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22993933)

  • 41. Dielectric relaxation and crystallization kinetics of ibuprofen at ambient and elevated pressure.
    Adrjanowicz K; Kaminski K; Wojnarowska Z; Dulski M; Hawelek L; Pawlus S; Paluch M; Sawicki W
    J Phys Chem B; 2010 May; 114(19):6579-93. PubMed ID: 20415466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin.
    Mallick S; Pattnaik S; Swain K; De PK; Saha A; Ghoshal G; Mondal A
    Eur J Pharm Biopharm; 2008 Feb; 68(2):346-51. PubMed ID: 17669640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure modeling, synthesis and X-ray diffraction determination of an extra-large calixarene-based coordination cage and its application in drug delivery.
    Du S; Yu TQ; Liao W; Hu C
    Dalton Trans; 2015 Aug; 44(32):14394-402. PubMed ID: 26200471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High shear mixing granulation of ibuprofen and beta-cyclodextrin: effects of process variables on ibuprofen dissolution.
    Ghorab MK; Adeyeye MC
    AAPS PharmSciTech; 2007 Oct; 8(4):E84. PubMed ID: 18181545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.
    Adeyeye CM; Price JC
    J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Ibuprofen release preferences of medicinal products, the market share of excipients vement of a polymer].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2010; 40(4):19-26. PubMed ID: 21387838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterisation of a novel conjugate of ibuprofen with 3-hydroxybutyric acid oligomers.
    Stasiak P; Ehrhardt C; Juzwa M; Sznitowska M
    J Pharm Pharmacol; 2009 Aug; 61(8):1119-24. PubMed ID: 19703357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen-cationic dextran conjugate crystanules.
    Abioye AO; Kola-Mustapha A; Chi GT; Ilya S
    Int J Pharm; 2014 Aug; 471(1-2):453-77. PubMed ID: 24886691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resolution of enantiomers of ibuprofen by liquid chromatography: a review.
    Bhushan R; Martens J
    Biomed Chromatogr; 1998; 12(6):309-16. PubMed ID: 9861488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
    Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
    Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solubility and dissolution rate of ibuprofen in ionic and non-ionic micellar systems.
    Kokot Z; Zmidzińska H
    Acta Pol Pharm; 2001; 58(2):117-20. PubMed ID: 11501788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides.
    Gordijo CR; Barbosa CA; Da Costa Ferreira AM; Constantino VR; de Oliveira Silva D
    J Pharm Sci; 2005 May; 94(5):1135-48. PubMed ID: 15793807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Passivation of high-surface-energy sites of milled ibuprofen crystals via dry coating for reduced cohesion and improved flowability.
    Han X; Jallo L; To D; Ghoroi C; Davé R
    J Pharm Sci; 2013 Jul; 102(7):2282-96. PubMed ID: 23658057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of a lipophilic drug on the stability of emulsions: an important approach on the development of lipidic carriers.
    Formiga FR; Fonseca IA; Souza KB; Silva AK; Macedo JP; Araújo IB; Soares LA; Egito ES
    Int J Pharm; 2007 Nov; 344(1-2):158-60. PubMed ID: 17614224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Commercially viable resolution of ibuprofen.
    Chávez-Flores D; Salvador JM
    Biotechnol J; 2009 Aug; 4(8):1222-4. PubMed ID: 19455529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation of ibuprofen-loaded chitosan films for oral mucosal drug delivery using supercritical solution impregnation.
    Tang C; Guan YX; Yao SJ; Zhu ZQ
    Int J Pharm; 2014 Oct; 473(1-2):434-41. PubMed ID: 25079432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Manipulating the physical states of confined ibuprofen in SBA-15 based drug delivery systems obtained by solid-state loading: Impact of the loading degree.
    Malfait B; Correia NT; Ciotonea C; Dhainaut J; Dacquin JP; Royer S; Tabary N; Guinet Y; Hédoux A
    J Chem Phys; 2020 Oct; 153(15):154506. PubMed ID: 33092366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
    Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scalemic mixtures preparation for optimized composition of ibuprofen solid dosage forms.
    Corvis Y; Guiblin N; Négrier P; Marenco I; Dembélé O; Espeau P
    Eur J Pharm Biopharm; 2021 Dec; 169():91-96. PubMed ID: 34571192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesoporous silica material TUD-1 as a drug delivery system.
    Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.